2m 2m 2m 2m 2m 2m 2m
BIOAFFINITY (BIAF)
NASDAQ
$3.18+$0.01 (+0.32%)
Price as of Oct 23, 2026 5:02 AM EDT- $4.6MMarket Cap
- -91.99%1-Year Change
- Diagnostics & ResearchIndustry
BIOAFFINITY (BIAF)
$3.18+$0.01 (+0.32%)
BIAF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.17 | ||
Change | -$0.40 (-11.20%) | ||
Open | $3.50 | ||
High | $3.73 | ||
Low | $3.14 | ||
Previous Close | $3.57 | ||
Volume | 90,624 | ||
30-Day Average Volume | 1,781,207 | ||
1-Week Change | -19.95% | ||
1-Month Change | -62.95% | ||
1-Year Change | -91.99% | ||
3-Year Change | -99.51% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.3M | ||
Total Assets | $7.6M | ||
Market Cap | $4.6M | ||
Enterprise Value | $2.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$3.3M | ||
EBIT | $0.00 | ||
EBITDA | $61,556.00 | ||
Net Working Capital | $1.2M | ||
EPS | -$9.60 | ||
Enterprise Value/EBITDA | 36 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 08/24/2026 | ||
Earnings & Revenue